43-year-old Kirsty Smith talks through her journey from being diagnosed with pulmonary hypertension in January 2001, to having her double lung transplant 15 years later.
After a lengthy battle for access, Selexipag was approved as a treatment for pulmonary hypertension across the UK in April 2019. We caught up with Neil Hamilton, consultant pharmacist at the Sheffield Pulmonary Vascular Disease Unit, to sort the fact from the fiction.
We are appreciative to Actelion Pharmaceuticals UK Ltd for an unrestricted grant to support the structure of this website. Actelion Pharmaceuticals Ltd have had no input into the contents of the website, which remains copyright to the PHA UK.